These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15643342)

  • 21. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects.
    de Gouw HW; Grünberg K; Schot R; Kroes AC; Dick EC; Sterk PJ
    Eur Respir J; 1998 Jan; 11(1):126-32. PubMed ID: 9543281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of Rhinovirus Immunity and Asthma.
    Yang Z; Mitländer H; Vuorinen T; Finotto S
    Front Immunol; 2021; 12():731846. PubMed ID: 34691038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.
    Zambrano JC; Carper HT; Rakes GP; Patrie J; Murphy DD; Platts-Mills TA; Hayden FG; Gwaltney JM; Hatley TK; Owens AM; Heymann PW
    J Allergy Clin Immunol; 2003 May; 111(5):1008-16. PubMed ID: 12743565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural and experimental rhinovirus infections of the lower respiratory tract.
    Johnston SL
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S46-52. PubMed ID: 7551413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.
    Gaido CM; Stone S; Chopra A; Thomas WR; Le Souëf PN; Hales BJ
    J Virol; 2016 Dec; 90(23):10459-10471. PubMed ID: 27630239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity.
    Feng X; Lawrence MG; Payne SC; Mattos J; Etter E; Negri JA; Murphy D; Kennedy JL; Steinke JW; Borish L
    Ann Allergy Asthma Immunol; 2022 Apr; 128(4):414-422.e2. PubMed ID: 35031416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhinovirus-induced asthma exacerbations and risk populations.
    Coleman L; Laing IA; Bosco A
    Curr Opin Allergy Clin Immunol; 2016 Apr; 16(2):179-85. PubMed ID: 26836624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update on the pathophysiology of rhinovirus upper respiratory tract infections.
    van Kempen M; Bachert C; Van Cauwenberge P
    Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
    Wark PA; Johnston SL; Bucchieri F; Powell R; Puddicombe S; Laza-Stanca V; Holgate ST; Davies DE
    J Exp Med; 2005 Mar; 201(6):937-47. PubMed ID: 15781584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhinovirus - From bench to bedside.
    To KKW; Yip CCY; Yuen KY
    J Formos Med Assoc; 2017 Jul; 116(7):496-504. PubMed ID: 28495415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human rhinoviruses, allergy, and asthma: a clinical approach.
    Emuzyte R; Firantiene R; Petraityte R; Sasnauskas K
    Medicina (Kaunas); 2009; 45(11):839-47. PubMed ID: 20051716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection.
    Jakiela B; Gielicz A; Plutecka H; Hubalewska-Mazgaj M; Mastalerz L; Bochenek G; Soja J; Januszek R; Aab A; Musial J; Akdis M; Akdis CA; Sanak M
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):229-41. PubMed ID: 24588727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhinovirus and asthma.
    Yamaya M; Sasaki H
    Viral Immunol; 2003; 16(2):99-109. PubMed ID: 12828863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages.
    Oliver BG; Lim S; Wark P; Laza-Stanca V; King N; Black JL; Burgess JK; Roth M; Johnston SL
    Thorax; 2008 Jun; 63(6):519-25. PubMed ID: 18245149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.
    Rochlitzer S; Hoymann HG; Müller M; Braun A;
    Clin Sci (Lond); 2014 Jan; 126(1):55-65. PubMed ID: 23822145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.
    Menzel M; Akbarshahi H; Bjermer L; Uller L
    Sci Rep; 2016 Jun; 6():28698. PubMed ID: 27350308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhinoviruses: important respiratory pathogens.
    Pitkäranta A; Hayden FG
    Ann Med; 1998 Dec; 30(6):529-37. PubMed ID: 9920354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
    Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
    Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How rhinovirus infections cause exacerbations of asthma.
    Gern JE
    Clin Exp Allergy; 2015 Jan; 45(1):32-42. PubMed ID: 25270551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic but not Healthy People.
    Jurak LM; Xi Y; Landgraf M; Carroll ML; Murray L; Upham JW
    Front Immunol; 2018; 9():1895. PubMed ID: 30174671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.